Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Discussion on critical points for a tailored therapy to cure hepatitis C virus infection

Nadia Marascio, Angela Quirino, Giorgio Settimo Barreca, Luisa Galati, Chiara Costa, Vincenzo Pisani, Maria Mazzitelli, Giovanni Matera, Maria Carla Liberto, Alfredo Focà, Carlo Torti

Clin Mol Hepatol. 2019;25(1):30-36. Published online January 23, 2019

DOI: https://doi.org/10.3350/cmh.2018.0061

View: 7840 Download: 153 Web of Science: 14 Crossref: 17

Original Article

Effect of antiviral therapy in reducing perinatal transmission of hepatitis B virus and maternal outcomes after discontinuing them

Kwang Il Seo, Si Hyun Bae, Pil Soo Sung, Chung-Hwa Park, Hae Lim Lee, Hee Yeon Kim, Hye Ji Kim, Bo Hyun Jang, Jeong Won Jang, Seung Kew Yoon, Jong Young Choi, In-Yang Park, Juyoung Lee, Hyun Seung Lee, Sa-Jin Kim, Jung Hyun Kwon, U Im Chang, Chang Wook Kim, Se Hyun Jo, Young Lee, Fisseha Tekle, Jong-Hyun Kim

Clin Mol Hepatol. 2018;24(4):374-383. Published online June 26, 2018

DOI: https://doi.org/10.3350/cmh.2017.0082

View: 8830 Download: 334 Web of Science: 1

Review

Management of hepatitis C viral infection in chronic kidney disease patients on hemodialysis in the era of direct-acting antivirals

Soon Young Ko, Won Hyeok Choe

Clin Mol Hepatol. 2018;24(4):351-357. Published online March 16, 2018

DOI: https://doi.org/10.3350/cmh.2017.0063

View: 9962 Download: 350 Web of Science: 4 Crossref: 1

Original Article

Interferon-free treatment for hepatitis C virus infection induces normalization of extrahepatic type I interferon signaling

Pil Soo Sung, Eun Byul Lee, Dong Jun Park, Angelo Lozada, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon

Clin Mol Hepatol. 2018;24(3):302-310. Published online March 12, 2018

DOI: https://doi.org/10.3350/cmh.2017.0074

View: 9838 Download: 185 Web of Science: 17 Crossref: 17

Review

Recent update of the 2017 Korean Association for the Study of the Liver (KASL) treatment guidelines of chronic hepatitis C: Comparison of guidelines from other continents, 2017 AASLD/IDSA and 2016 EASL

Jong Eun Yeon

Clin Mol Hepatol. 2018;24(3):278-293. Published online May 2, 2018

DOI: https://doi.org/10.3350/cmh.2018.1002

View: 10437 Download: 237 Web of Science: 13 Crossref: 12

2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C

Clin Mol Hepatol. 2018;24(3):169-229. Published online August 10, 2018

DOI: https://doi.org/10.3350/cmh.2018.1004

View: 14580 Download: 222 Web of Science: 20 Crossref: 27

Original Article

Evolution of glomerular filtration rates and neutrophil gelatinase-associated lipocalin during treatment with direct acting antivirals

Alessio Strazzulla, Giuseppe Coppolino, Giorgio Settimo Barreca, Innocenza Gentile, Laura Rivoli, Maria Concetta Postorino, Maria Mazzitelli, Giuseppe Greco, Chiara Costa, Vincenzo Pisani, Nadia Marascio, Mariadelina Simeoni, Alfredo Focà, Giorgio Fuiano, Daniela Foti, Elio Gulletta, Carlo Torti

Clin Mol Hepatol. 2018;24(2):151-162. Published online April 24, 2018

DOI: https://doi.org/10.3350/cmh.2017.0059

View: 6778 Download: 119 Web of Science: 14 Crossref: 13

Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B

Won Sohn, Ju-Yeon Cho, Ji Hoon Kim, Jung Il Lee, Hyung Joon Kim, Min-Ah Woo, Sin-Ho Jung, Yong-Han Paik

Clin Mol Hepatol. 2017;23(2):170-178. Published online May 16, 2017

DOI: https://doi.org/10.3350/cmh.2016.0086

View: 9700 Download: 224 Web of Science: 52 Crossref: 45

Barriers to treatment of failed or interferon ineligible patients in the era of DAA: single center study

Kwang Il Seo, Byung Chul Yun, Weiquan James Li, Sang Uk Lee, Byung Hoon Han, Eun Taek Park

Clin Mol Hepatol. 2017;23(1):74-79. Published online March 3, 2017

DOI: https://doi.org/10.3350/cmh.2016.0052

View: 7675 Download: 147 Web of Science: 2 Crossref: 2

Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization

Sun Hong Yoo, Jeong Won Jang, Jung Hyun Kwon, Seung Min Jung, Bohyun Jang, Jong Young Choi

Clin Mol Hepatol. 2016;22(4):458-465. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0054

View: 9011 Download: 134 Web of Science: 10 Crossref: 10

Review

Management of direct antiviral agent failures

María Buti, Rafael Esteban

Clin Mol Hepatol. 2016;22(4):432-438. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0107

View: 11284 Download: 364 Web of Science: 29 Crossref: 27

Original Article

Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B

Jaemin Lee, Sun Hong Yoo, Won Sohn, Hyung Woo Kim, Yong Sun Choi, Jung Ho Won, Jin Young Heo, Sang Jong Park, Young Min Park

Clin Mol Hepatol. 2016;22(3):339-349. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0021

View: 11857 Download: 164 Web of Science: 19 Crossref: 19

Review

The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy

Ioannis Varbobitis, George V. Papatheodoridis

Clin Mol Hepatol. 2016;22(3):319-326. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0045

View: 13498 Download: 397 Web of Science: 69 Crossref: 71

Original Article

Efficacy and safety of daclatasvir and asunaprevir for hepatitis C virus genotype 1b infection

Hee Chul Nam, Hae Lim Lee, Hyun Yang, Myeong Jun Song

Clin Mol Hepatol. 2016;22(2):259-266. Published online June 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0020

View: 9574 Download: 165 Web of Science: 8 Crossref: 7

Sofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in Korea

Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim

Clin Mol Hepatol. 2015;21(4):358-364. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.358

View: 8440 Download: 103 Web of Science: 12 Crossref: 11

Review

Management of viral hepatitis in liver transplant recipients

Soung Won Jeong, YoungRok Choi, Jin-Wook Kim

Clin Mol Hepatol. 2014;20(4):338-344. Published online December 24, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.4.338

View: 8676 Download: 80 Web of Science: 3 Crossref: 3

Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade

Hyung Joon Yim, Seong Gyu Hwang

Clin Mol Hepatol. 2013;19(3):195-209. Published online September 30, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.3.195

View: 11738 Download: 71 Crossref: 24

Chronic hepatitis B in pregnancy: unique challenges and opportunities

Kumaresan Yogeswaran, Scott K. Fung

Clin Mol Hepatol. 2011;17(1):1-8. Published online March 21, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.1.1

View: 8149 Download: 66 Crossref: 16

Current status of Liver diseases in Korea: Hepatitis B

Hee Bok Chae , Jong Hyun Kim , Ja Kyung Kim , Hyung Joon Yim

Clin Mol Hepatol. 2009;15(60):13-24. Published online December 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.S6.S13

View: 8263 Download: 98 Crossref: 75

3

Analysis of the cost-effectiveness of antiviral therapies in chronic hepatitis B patients in Korea

Byung Kook Kim, M.D., So Young Kwon, M.D., Chang Hong Lee, M.D., Won Hyeok Choe, M.D., Hong Mi Choi, M.S. Hye Won Koo, M.D.

Clin Mol Hepatol. 2009;15(1):25-41. Published online March 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.1.25

View: 5286 Download: 55 Crossref: 3

2

Hepatitis B virus genetic diversity and mutant

Hyung Joon Yim

Clin Mol Hepatol. 2008;14(4):446-464. Published online December 31, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.4.446

View: 6661 Download: 145 Crossref: 9

HBV Mutations During Antiviral Therapy in Patients with Chronic Hepatits B

Seong Gyu Hwang

Clin Mol Hepatol. 2005;11(4):311-319. Published online January 1, 1970

View: 2387 Download: 14

Treatment of Chronic Hepatitis B ; Antiviral Therapy in Hepatitis B Carriers Undergoing Immunosuppressive Treatment or Cytotoxic Chemotherapy

Jung Hwan Yoon

Clin Mol Hepatol. 2005;11(1):17-20. Published online January 1, 2000

View: 2329 Download: 12

Treatment of Chronic Hepatitis B ; Monitoring Patients with Chronic HBV Infection During Antiviral Therapy

Yun Soo Kim

Clin Mol Hepatol. 2005;11(1):9-12. Published online January 1, 2000

View: 2436 Download: 17

Editorial

Nucleos(t)ide Analog Therapy of Chronic Hepatitis B and Extrahepatic Cancer Risk: Is tenofovir better than entecavir?

Yewan Park, Dong Hyun Sinn

Received July 4, 2024 Accepted July 7, 2024

DOI: https://doi.org/10.3350/cmh.2024.0519 [Accepted]

View: 137 Download: 21

1 | 2 |

Viewed By 5505	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5413	MAFLD: How is it different from NAFLD?
Viewed By 5222	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5101	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4732	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 176	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 113	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 108	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 90	MAFLD: How is it different from NAFLD?
Cited By 80	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search